Literature DB >> 4862170

Chemical modifications and biological properties of rifamycins.

P Sensi, N Maggi, S Füresz, G Maffii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4862170

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  13 in total

1.  Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents.

Authors:  Rajendra P Tangallapally; Raghunandan Yendapally; Robin E Lee; Anne J M Lenaerts; Richard E Lee
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

2.  Inhibition of poxvirus maturation by rifamycin derivatives and related compounds.

Authors:  T H Pennington; E A Follett
Journal:  J Virol       Date:  1971-06       Impact factor: 5.103

Review 3.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

4.  Rifampicin in plasma and pleural fluid after single oral doses.

Authors:  G Boman; A S Malmborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

6.  In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Rifampicin inhibition of ribonucleic acid and protein synthesis in normal and ethylenediaminetetraacetic acid-treated Escherichia coli.

Authors:  P Reid; J Speyer
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

8.  In vitro effect of rifampin on mycobacteria.

Authors:  V Lorian; M Finland
Journal:  Appl Microbiol       Date:  1969-02

9.  Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.

Authors:  Tamara Staudinger; Bernhard Redl; Ben J Glasgow
Journal:  Biochim Biophys Acta       Date:  2014-02-12

10.  Spiropiperidyl rifabutins: expanded in vitro testing against ESKAPE pathogens and select bacterial biofilms.

Authors:  Marıa-Paz Cabal; Timothy E Long; Edward Turos; Ana-Belén García; Jessie L Allen; Bridget G Budny; Lindsey N Shaw
Journal:  J Antibiot (Tokyo)       Date:  2020-07-10       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.